Just in Time for Summer Sandal Season: Valeant’s Jublia® Approved for Onychomycosis
The US Food and Drug Administration (FDA) has approved Jublia® (efinaconazole 10% topical solution) for the treatment of onychomycosis of the toenails.
The US Food and Drug Administration (FDA) has approved Jublia® (efinaconazole 10% topical solution) for the treatment of onychomycosis of the toenails.
Available in the EU, UK, and Switzerland, the device is designed for in-office preparation of autologous PRP and Fluid-PRF.